Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves-Reference-Cited by-同舟云学术

Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves

Published:2017-03-28 Issue:13 Volume:135 Page:1273-1275
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Carnicelli Anthony P.¹,De Caterina Raffaele¹,Halperin Jonathan L.¹,Renda Giulia¹,Ruff Christian T.¹,Trevisan Marco¹,Nordio Francesco¹,Mercuri Michele F.¹,Antman Elliott¹,Giugliano Robert P.¹

Affiliation:

1. From Brigham & Women’s Hospital, Harvard Medical School, Boston, MA (A.P.C.); Institute of Cardiology and Center of Excellence on Aging, G. d’Annunzio University, Chieti, Italy (R.D.C., G.R.); Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York (J.L.H.); TIMI Study Group (Thrombolysis in Myocardial Infarction), Boston, MA (C.T.R., M.T., F.N., E.A., R.P.G.); and Daiichi Sankyo Pharma Development, Edison, NJ (M.P.M.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Burden of valvular heart diseases: a population-based study

2. National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements

3. Abstract 17277: Apixaban Use in Patients With Atrial Fibrillation With Bioprosthetic Valves: Insights From ARISTOTLE

4. Edoxaban versus Warfarin in Patients with Atrial Fibrillation

5. OUTCOMES IN 2824 PATIENTS WITH VALVULAR HEART DISEASE TREATED WITH EDOXABAN OR WARFARIN IN THE ENGAGE AF-TIMI 48 TRIAL

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical effects of direct oral anticoagulants in elderly patients with a bioprosthetic valve and atrial fibrillation;International Journal of Cardiology;2024-10

2. The balance between thrombosis and bleeding after mitral valve surgery: The need for robust evidence;Revista Portuguesa de Cardiologia;2024-09

3. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Compared with Vitamin K Antagonists in Patients with Atrial Fibrillation and Type 2 Valvular Heart Disease: A Systematic Review and Meta-Analysis;Cardiovascular Drugs and Therapy;2024-08-17

4. Mechanical Aortic Valve Thrombosis During Anticoagulation Using Oral Rivaroxaban: A Case Report;Cureus;2024-07-20

5. Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: Rationale and Design of the ENBALV Trial;Cardiovascular Drugs and Therapy;2024-06-24